Rectal misoprostol vs 15-methyl prostaglandin F for retained placenta after second-trimester delivery

Subha Sundaram, John P. Diaz, Víctor Hugo González-Quintero, Usha Verma

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: The purpose of this study was to compare rectal misoprostol (RM) with 15-methyl prostaglandin F2α (PGF) for the management of retained placenta after second-trimester deliveries. Study Design: A retrospective study of all second-trimester deliveries between the years 2000 and 2005 was performed. Women were divided into 2 groups, depending on whether they received RM or PGF after the delivery. Results: Three hundred three second-trimester deliveries were analyzed. The time from the administration of medications to the placental delivery was significantly shorter in women who received PGF, compared with the RM group (49.5 vs 89 minutes; P < .01). Women who received PGF had lower rates of retained placenta (4.9% vs 12.4%; P = .02). Conclusion: The use of PGF after second-trimester deliveries results in shorter third stage of labor and lower rates of retained placenta compared with RM.

Original languageEnglish
JournalAmerican Journal of Obstetrics and Gynecology
Volume200
Issue number5
DOIs
StatePublished - May 1 2009

Fingerprint

Retained Placenta
Misoprostol
Dinoprost
Second Pregnancy Trimester
Third Labor Stage
Retrospective Studies

Keywords

  • misoprostol
  • prostaglandin F
  • retained placenta
  • second-trimester delivery

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Rectal misoprostol vs 15-methyl prostaglandin F for retained placenta after second-trimester delivery. / Sundaram, Subha; Diaz, John P.; González-Quintero, Víctor Hugo; Verma, Usha.

In: American Journal of Obstetrics and Gynecology, Vol. 200, No. 5, 01.05.2009.

Research output: Contribution to journalArticle

@article{a38108d530754f93b0b9529d9b9095e3,
title = "Rectal misoprostol vs 15-methyl prostaglandin F2α for retained placenta after second-trimester delivery",
abstract = "Objective: The purpose of this study was to compare rectal misoprostol (RM) with 15-methyl prostaglandin F2α (PGF2α) for the management of retained placenta after second-trimester deliveries. Study Design: A retrospective study of all second-trimester deliveries between the years 2000 and 2005 was performed. Women were divided into 2 groups, depending on whether they received RM or PGF2α after the delivery. Results: Three hundred three second-trimester deliveries were analyzed. The time from the administration of medications to the placental delivery was significantly shorter in women who received PGF2α, compared with the RM group (49.5 vs 89 minutes; P < .01). Women who received PGF2α had lower rates of retained placenta (4.9{\%} vs 12.4{\%}; P = .02). Conclusion: The use of PGF2α after second-trimester deliveries results in shorter third stage of labor and lower rates of retained placenta compared with RM.",
keywords = "misoprostol, prostaglandin F, retained placenta, second-trimester delivery",
author = "Subha Sundaram and Diaz, {John P.} and Gonz{\'a}lez-Quintero, {V{\'i}ctor Hugo} and Usha Verma",
year = "2009",
month = "5",
day = "1",
doi = "10.1016/j.ajog.2008.09.868",
language = "English",
volume = "200",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Rectal misoprostol vs 15-methyl prostaglandin F2α for retained placenta after second-trimester delivery

AU - Sundaram, Subha

AU - Diaz, John P.

AU - González-Quintero, Víctor Hugo

AU - Verma, Usha

PY - 2009/5/1

Y1 - 2009/5/1

N2 - Objective: The purpose of this study was to compare rectal misoprostol (RM) with 15-methyl prostaglandin F2α (PGF2α) for the management of retained placenta after second-trimester deliveries. Study Design: A retrospective study of all second-trimester deliveries between the years 2000 and 2005 was performed. Women were divided into 2 groups, depending on whether they received RM or PGF2α after the delivery. Results: Three hundred three second-trimester deliveries were analyzed. The time from the administration of medications to the placental delivery was significantly shorter in women who received PGF2α, compared with the RM group (49.5 vs 89 minutes; P < .01). Women who received PGF2α had lower rates of retained placenta (4.9% vs 12.4%; P = .02). Conclusion: The use of PGF2α after second-trimester deliveries results in shorter third stage of labor and lower rates of retained placenta compared with RM.

AB - Objective: The purpose of this study was to compare rectal misoprostol (RM) with 15-methyl prostaglandin F2α (PGF2α) for the management of retained placenta after second-trimester deliveries. Study Design: A retrospective study of all second-trimester deliveries between the years 2000 and 2005 was performed. Women were divided into 2 groups, depending on whether they received RM or PGF2α after the delivery. Results: Three hundred three second-trimester deliveries were analyzed. The time from the administration of medications to the placental delivery was significantly shorter in women who received PGF2α, compared with the RM group (49.5 vs 89 minutes; P < .01). Women who received PGF2α had lower rates of retained placenta (4.9% vs 12.4%; P = .02). Conclusion: The use of PGF2α after second-trimester deliveries results in shorter third stage of labor and lower rates of retained placenta compared with RM.

KW - misoprostol

KW - prostaglandin F

KW - retained placenta

KW - second-trimester delivery

UR - http://www.scopus.com/inward/record.url?scp=64249151012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64249151012&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2008.09.868

DO - 10.1016/j.ajog.2008.09.868

M3 - Article

C2 - 19136084

AN - SCOPUS:64249151012

VL - 200

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 5

ER -